JENNIFER P KELLEY

Allopathic & Osteopathic Physicians|Internal Medicine BOSSIER CITY, LA NPI 1366760993

General Payments — all program years on this page

$1,271.90

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 72
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $328.35 across 18 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $328.3518

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Corium, Inc. $112.296
Acerta Pharma LLC $82.215
Novo Nordisk AS $55.863
Merck Sharp & Dohme Corporation $53.423
IRONWOOD PHARMACEUTICALS, INC $24.571

By program year

Program yearAmountRecords
2018 $86.726
2019 $59.144
2020 $131.109
2021 $204.7412
2022 $174.2910
2023 $287.5613
2024 $328.3518

Records — PY2024 (18)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1097137562 Novo Nordisk Inc $19.14 09/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097421700 Novo Nordisk Inc $15.32 05/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097670536 Novo Nordisk Inc $21.40 02/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100084038 Corium, LLC $24.74 04/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100119522 Corium, LLC $11.93 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100137125 Corium, LLC $1.47 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100157607 Corium, LLC $11.51 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100199206 Corium, LLC $29.00 09/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100204938 Corium, LLC $33.64 07/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104202517 AstraZeneca Pharmaceuticals LP $19.55 07/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104435735 AstraZeneca Pharmaceuticals LP $16.53 11/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105630555 AstraZeneca Pharmaceuticals LP $17.13 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105669369 AstraZeneca Pharmaceuticals LP $14.04 03/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105738329 AstraZeneca Pharmaceuticals LP $14.96 10/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141782785 Merck Sharp & Dohme LLC $20.10 04/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141894531 Merck Sharp & Dohme LLC $13.21 07/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141942819 Merck Sharp & Dohme LLC $20.11 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153718784 IRONWOOD PHARMACEUTICALS, INC $24.57 03/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.